Endoscopy-coupled Raman spectroscopy for in vivo discrimination of inflammatory bowel disease

I. J. Pence; Q. T. Nguyen; X. Bi; A. J. Herline M.D.; D. M. Beaulieu; S. N. Horst; D. A. Schwartz; A. Mahadevan-Jansen

doi:10.1117/12.2042795

4 March 2014 Endoscopy-coupled Raman spectroscopy for in vivo discrimination of inflammatory bowel disease

I. J. Pence, Q. T. Nguyen, X. Bi, A. J. Herline M.D., D. M. Beaulieu, S. N. Horst, D. A. Schwartz, A. Mahadevan-Jansen

Proceedings Volume 8939, Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry; 89390R (2014) https://doi.org/10.1117/12.2042795
Event: SPIE BiOS, 2014, San Francisco, California, United States

Abstract

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s colitis (CC), affects nearly 2 million Americans, and the incidence is increasing worldwide. It has been established that UC and CC are distinct forms of IBD and require different medical care, however the distinction made between UC and CC is based upon inexact clinical, radiological, endoscopic, and pathologic features. A diagnosis of indeterminate colitis occurs in up to 15% of patients when UC and CC features overlap and cannot be differentiated; in these patients, diagnosis relies on long term followup, success or failure of existing treatment, and recurrence of the disease. Thus, there is need for a tool that can improve the sensitivity and specificity for fast, accurate and automated diagnosis of IBD. Here we present colonoscopy-coupled fiber probe-based Raman spectroscopy as a novel in vivo diagnostic tool for IBD. This in vivo study of both healthy control (NC, N=10) and diagnosed IBD patients with UC (N=15) and CC (N=26) aims to characterize spectral signatures of NC, UC, and CC. Samples are correlated with tissue pathology markers and endoscopic evaluation. Optimal collection parameters for detection have been identified based upon the new, application specific instrument design. The collected spectra are processed and analyzed using multivariate statistical techniques to identify spectral markers and discriminate NC, UC, and CC. Development of spectral markers to discriminate disease type is a necessary first step in the development of real-time, accurate and automated in vivo detection of IBD during colonoscopy procedures.

Citation Download Citation

I. J. Pence, Q. T. Nguyen, X. Bi, A. J. Herline M.D., D. M. Beaulieu, S. N. Horst, D. A. Schwartz, and A. Mahadevan-Jansen "Endoscopy-coupled Raman spectroscopy for in vivo discrimination of inflammatory bowel disease", Proc. SPIE 8939, Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry, 89390R (4 March 2014); https://doi.org/10.1117/12.2042795

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available